Physician profile
Jacob Mathew
NPI 1407160187
$1,630.65
in general payments reported to CMS, 2019-2025
18 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.62 · 2020: $106 · 2021: $78.27 · 2022: $605 · 2023: $109 · 2024: $282 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $536.78 | 2021-2025 | Giapreza |
| Astrazeneca Pharmaceuticals LP | $236.82 | 2022-2024 | Andexxa |
| Abbvie INC. | $164.54 | 2025 | |
| Chiesi USA, INC. | $115.22 | 2024 | Cleviprex, Kengreal |
| Portola Pharmaceuticals, LLC | $105.70 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.96 | 2022 | |
| Merck Sharp & Dohme LLC | $65.35 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
| Shionogi INC | $49.20 | 2024-2025 | Fetroja |
| Inari Medical, INC. | $43.45 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Melinta Therapeutics, LLC | $40.86 | 2022-2023 | Rezzayo, Kimyrsa, Orbactiv |
| Allergan, INC. | $37.80 | 2019 | |
| Stryker Corporation | $27.72 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Gilead Sciences, INC. | $26.79 | 2022-2023 | |
| Insmed, INC. | $19.70 | 2025 | Arikayce |
| Csl Behring | $17.98 | 2023 | Kcentra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.34 | 2024 | Xarelto |
| Masimo Corporation | $16.26 | 2024 | Sedline |
| Heron Therapeutics, INC. | $14.18 | 2025 | Aponvie |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.